Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Milestone Scientific (MLSS) EBITDA (2016 - 2025)

Historic EBITDA for Milestone Scientific (MLSS) over the last 16 years, with Q3 2025 value amounting to -$1.1 million.

  • Milestone Scientific's EBITDA rose 2278.2% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.7 million, marking a year-over-year increase of 13.88%. This contributed to the annual value of -$6.8 million for FY2024, which is 431.26% up from last year.
  • Latest data reveals that Milestone Scientific reported EBITDA of -$1.1 million as of Q3 2025, which was up 2278.2% from -$1.5 million recorded in Q2 2025.
  • In the past 5 years, Milestone Scientific's EBITDA ranged from a high of -$984373.0 in Q1 2021 and a low of -$2.9 million during Q2 2022
  • Moreover, its 5-year median value for EBITDA was -$1.9 million (2022), whereas its average is -$1.8 million.
  • As far as peak fluctuations go, Milestone Scientific's EBITDA soared by 3880.58% in 2021, and later crashed by 9448.76% in 2022.
  • Over the past 5 years, Milestone Scientific's EBITDA (Quarter) stood at -$1.6 million in 2021, then fell by 28.97% to -$2.0 million in 2022, then rose by 1.74% to -$2.0 million in 2023, then decreased by 5.34% to -$2.1 million in 2024, then skyrocketed by 45.6% to -$1.1 million in 2025.
  • Its EBITDA was -$1.1 million in Q3 2025, compared to -$1.5 million in Q2 2025 and -$2.0 million in Q1 2025.